These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18620015)

  • 1. Are adolescents ready for tuberculosis vaccine trials?
    Mahomed H; Shea J; Kafaar F; Hawkridge T; Hanekom WA; Hussey GD
    Vaccine; 2008 Aug; 26(36):4725-30. PubMed ID: 18620015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engaging adolescents in tuberculosis and clinical trial research through drama.
    Schmidt BM; Abrams A; Tameris M
    Trials; 2016 Apr; 17():177. PubMed ID: 27048474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Willingness to participate in HIV vaccine research in a peri-urban South African community.
    Smit J; Middelkoop K; Myer L; Seedat S; Bekker LG; Stein DJ
    Int J STD AIDS; 2006 Mar; 17(3):176-9. PubMed ID: 16510005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motivations and concerns about adolescent tuberculosis vaccine trial participation in rural Uganda: a qualitative study.
    Buregyeya E; Kulane A; Kiguli J; Musoke P; Mayanja H; Mitchell EM
    Pan Afr Med J; 2015; 22():76. PubMed ID: 26834929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local knowledge and experiences of vaccination: implications for HIV-preventive vaccine trials in South Africa.
    Lindegger G; Quayle M; Ndlovu M
    Health Educ Behav; 2007 Feb; 34(1):108-23. PubMed ID: 16740504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of time to regulatory and ethical approval of SATVI TB vaccine trials in South Africa.
    Geldenhuys H; Veldsman A; Tameris M; Luabeya A; Hanekom W; Mahomed H; Hatherill M
    S Afr Med J; 2012 Nov; 103(2):85-9. PubMed ID: 23374302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development.
    Dietrich J; Doherty TM
    APMIS; 2009 May; 117(5-6):440-57. PubMed ID: 19400867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood tuberculosis: old and new vaccines.
    Hussey G; Hawkridge T; Hanekom W
    Paediatr Respir Rev; 2007 Jun; 8(2):148-54. PubMed ID: 17574159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge of tuberculosis and vaccine trial preparedness in Lima, Peru.
    Shu E; Sobieszczyk ME; Sal Y Rosas VG; Segura P; Galea JT; Lecca L; Sanchez J; Lama JR
    Int J Tuberc Lung Dis; 2017 Dec; 21(12):1288-1293. PubMed ID: 29297450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is intranasal vaccination a feasible solution for tuberculosis?
    Giri PK; Khuller GK
    Expert Rev Vaccines; 2008 Nov; 7(9):1341-56. PubMed ID: 18980538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real world TB vaccines: clinical trials in TB-endemic regions.
    Doherty TM
    Vaccine; 2005 Mar; 23(17-18):2109-14. PubMed ID: 15755580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Key issues in the clinical development and implementation of TB vaccines in South Africa.
    Rustomjee R; Mcleod R; Hanekom W; Steel G; Mahomed H; Hawkridge A; Welte A; Sinanovic E; Loots G; Grobler A; Mvusi L; Gray G; Hesseling A; Ginsberg A; Lienhardt C; Shea J; Tong X; Lockhart S; Churchyard GJ
    Tuberculosis (Edinb); 2012 Sep; 92(5):359-64. PubMed ID: 22698868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing tuberculosis management in rural south-west Kenya.
    Mochache LN; Nyamongo IK
    Int J Tuberc Lung Dis; 2009 Jul; 13(7):895-9. PubMed ID: 19555541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No decrease in annual risk of tuberculosis infection in endemic area in Cape Town, South Africa.
    Kritzinger FE; den Boon S; Verver S; Enarson DA; Lombard CJ; Borgdorff MW; Gie RP; Beyers N
    Trop Med Int Health; 2009 Feb; 14(2):136-42. PubMed ID: 19236665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trials of TB vaccines: harmonization and cooperation.
    Mahomed H; Fourie PB
    Tuberculosis (Edinb); 2012 Mar; 92 Suppl 1():S21-4. PubMed ID: 22441155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential barriers to HPV vaccine provision among medical practices in an area with high rates of cervical cancer.
    Keating KM; Brewer NT; Gottlieb SL; Liddon N; Ludema C; Smith JS
    J Adolesc Health; 2008 Oct; 43(4 Suppl):S61-7. PubMed ID: 18809147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tuberculosis vaccines].
    Wiker HG; Bjune G
    Tidsskr Nor Laegeforen; 2006 Oct; 126(20):2678-81. PubMed ID: 17057769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
    Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
    Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing cervical cancer through human papillomavirus vaccination: perspective from focus groups.
    Wong LP
    J Low Genit Tract Dis; 2009 Apr; 13(2):85-93. PubMed ID: 19387128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A qualitative assessment of perspectives on the inclusion of adolescents in HIV vaccine trials in South Africa.
    Jaspan HB; Soka NF; Mathews C; Flisher AJ; Mark D; Middelkoop K; Wood R; Bekker LG
    Int J STD AIDS; 2010 Mar; 21(3):172-6. PubMed ID: 20215620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.